PET Imaging-Based Evaluaion of Hepaobiliary transport in Humans with [18F]PTV
Not Applicable
- Conditions
- Healthy adult
- Registration Number
- JPRN-UMIN000030049
- Lead Sponsor
- RIKEN Center for Biosystems Dynamics Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 8
Inclusion Criteria
Not provided
Exclusion Criteria
1.those who have compligating disordes of severe cenral nervous system, liver, and kidney damage. 2.those who take hyperlipidemia treatment, tuberculosis drug and other treatments for target regions. 3.those who are claustrophobia. 4.those who are not suiable for this study assessed by medical docors judge
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Disribution of Radioacivity in human dbdominal region and blood after adminisration of [18F]PTV
- Secondary Outcome Measures
Name Time Method metabolite analysis of human blood by TLC
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular transporters does [18F]PTV target in hepaticobiliary imaging studies?
How does [18F]PTV PET imaging compare to standard biliary function assessment methods in healthy adults?
Which biomarkers correlate with hepaticobiliary transporter activity in [18F]PTV PET studies?
What adverse events are associated with [18F]PTV radiotracer administration in clinical trials?
Are there alternative radiotracers for hepaticobiliary transport evaluation in RIKEN-sponsored PET studies?